Biomarkers of systemic treatment response in people with psoriasis: a scoping review

BACKGROUND: Responses to the systemic treatments commonly used to treat psoriasis vary. Biomarkers that accurately predict effectiveness and safety would enable targeted treatment selection, improved patient outcomes and more cost‐effective healthcare. OBJECTIVES: To perform a scoping review to iden...

Descripción completa

Detalles Bibliográficos
Autores principales: Corbett, Mark, Ramessur, Ravi, Marshall, David, Acencio, Marcio L., Ostaszewski, Marek, Barbosa, Ines A., Dand, Nick, Di Meglio, Paola, Haddad, Salma, Jensen, Andreas H.M., Koopmann, Witte, Mahil, Satveer K., Rahmatulla, Seher, Rastrick, Joe, Saklatvala, Jake, Weidinger, Stephan, Wright, Kath, Eyerich, Kilian, Barker, Jonathan N., Ndlovu, Matladi, Conrad, Curdin, Skov, Lone, Smith, Catherine H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Evidence‐Based Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796396/
https://www.ncbi.nlm.nih.gov/pubmed/35606928
http://dx.doi.org/10.1111/bjd.21677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796396/
https://www.ncbi.nlm.nih.gov/pubmed/35606928
http://dx.doi.org/10.1111/bjd.21677

Ejemplares similares